Astrid De Cuyper - Concepedia

Author

Astrid De Cuyper

Cliniques Universitaires Saint-Luc

Also Known As

A De Cuyper, A. De Cuyper, Astrid De Cuyper, Selda Aydin

Publications

212

Citations

H-Index

Concepts

All Affiliations

Cliniques Universitaires Saint-Luc Grand Charleroi Hospital Hôpital de Jolimont UCLouvain Université Libre de Bruxelles

About

Astrid De Cuyper is an author at Cliniques Universitaires Saint-Luc specializing in pathology, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	87
2	Health Sciences	3	3	61
3	Immunology	3	3	65
4	Gastroenterology	1	1	22
5	Hepatology	1	1	22

Astrid De Cuyper

Publications

133

Citations

H-Index

Page 1

	Year	Citations
Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study. Marc Van den Eynde, Nicolas D. Huyghe, Astrid De Cuyper, Journal of Clinical Oncology Avetuxiri TrialImmunologyImmunoeditingPathologyImmunotherapeutics	2021	29
Regorafenib induced severe toxic hepatitis: characterization and discussion Anne Sacré, Nicolas Lanthier, Hélène Dano, Liver International	2016	26
397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer Javier Carrasco, D Schröder, Isabelle Sinapi, Annals of Oncology MedicineR-immune Interim AnalysisImmunologyPathologyImmune Checkpoint Inhibitor	2021	26
Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases Alice Boilève, Astrid De Cuyper, Alicia Larive, European Journal of Cancer Systemic ChemotherapyHepatologyHealth SciencesGastrointestinal OncologyMedicine	2020	22
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study Cédric van Marcke, Natasha Honoré, A. van der Elst, BMC Cancer	2021	10
Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Nicolas D. Huyghe, Astrid De Cuyper, Isabelle Sinapi, Journal of Clinical Oncology Avetuxiri TrialImmunologyPathologyImmunotherapeuticsImmunotherapy	2022	10
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer Alessandro Audisio, Chiara Gallio, Vaneja Velenik, JAMA Oncology	2025	10

Page 1